| Prashant Kohli |
Prashant Kohli is currently the Chief Executive Officer & Director at Acasti Pharma, Inc. He previously worked as the Vice President-Commercial Operations at Grace Therapeutics LLC. Mr. Kohli completed his undergraduate degree at Augustana College (Illinois) and holds undergraduate and MBA degrees from The Wharton School of the University of Pennsylvania. |
| Carrie D'Andrea |
Carrie D'Andrea is currently the Vice President-Clinical Operations at Acasti Pharma, Inc. She previously held the same position at Edge Therapeutics, Inc. from 2014 to 2019 and at EryDel SpA from 2020 to 2021. She is a graduate of Temple University (Pennsylvania). |
| Robert Loch Macdonald |
Robert Loch Macdonald founded Edge Therapeutics, Inc. in 2009, where he worked as Director & Chief Scientific Officer from 2009 to 2018. Dr. Macdonald also currently works at Community Health Partners, as Medical Director, St. Michael's Hospital, as Head-Neurosurgery Division, and Acasti Pharma, Inc., as Chief Medical Officer from 2023. Dr. Macdonald also formerly worked at The University of Chicago Medical Center, as Professor and the University of Toronto, as Professor from 2007 to 2015. Dr. Macdonald received his doctorate degree from the University of Alberta and graduate degree from the University of British Columbia. |
| Vimal Kumar Kavuru |
Vimal Kumar Kavuru is the founder. He founded Celon Laboratories Ltd. in 2007, Rising Pharmaceuticals, Inc. in 2016, Citron Pharma LLC in 2013, Gen-Source RX in 2008, and Cronus Pharma LLC in 2016. At Rising Pharmaceuticals, Inc., he holds the title of President & Chief Executive Officer starting in 2016. At Citron Pharma LLC, he holds the title of Chief Executive Officer starting in 2013. At Gen-Source RX, he held the title of Chief Executive Officer from 2008 to 2013. At Cronus Pharma LLC, he holds the title of Director starting in 2016. Mr. Kavuru is also the founder of Grace Therapeutics LLC, Shore Suven Pharma, Inc., and Acetris Pharma Holdings LLC. Mr. Kavuru's current job(s) include being the President & Chief Executive Officer at Casper Pharma LLC, the Chief Executive Officer at Lucid Pharma LLC since 2013, the Chairman at Acasti Pharma, Inc. since 2021, and the Director at Mviyes Pharma Ventures Pvt Ltd. since 2018. Mr. Kavuru's former job(s) include being a Director at Actylis Corp. from 2017 to 2019. Mr. Kavuru's education history includes studying at HKES College of Pharmacy, where he obtained an undergraduate degree. |
| Robert J. DelAversano |
Robert J. DelAversano is currently the Chief Financial & Accounting Officer at Acasti Pharma, Inc. and the Vice President-Finance & Controller at OncoSec Medical, Inc. Previously, he worked as the Director-Financial Reporting & Taxation at Brio Consultants LLC and as the Chief Financial & Accounting Officer at U.S. Gold Corp. from 2017 to 2018. He also served as a Manager at Bartolomei Pucciarelli LLC. Mr. DelAversano completed his undergraduate degree at Rider University. |
| Santosh George Kottayil |
Santosh George Kottayil was the founder of InSys Therapeutics, Inc. which was founded in 2002, where he held the titles of President & Executive Vice President-Technology. Dr. Kottayil is also the founder of Grace Therapeutics LLC. Currently, he is a Director at Acasti Pharma, Inc. since 2023. Previously, he worked as the Chief Operating Officer-US at Acasti Pharma, Inc. Dr. Kottayil earned a doctorate degree from the University of Kentucky. |
